Endogenous sex hormones, breast cancer risk, and tamoxifen response: an ancillary study in the NSABP Breast Cancer Prevention Trial (P-1).

Source:http://linkedlifedata.com/resource/pubmed/id/16418513

J. Natl. Cancer Inst. 2006 Jan 18 98 2 110-5

Download in:

View as

General Info

PMID
16418513